NCT07444385

A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects

An Open-Label, Randomized, Single-Dose, Two-Sequence, Two-Period Crossover Clinical Trial to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Volunteers Under Fed Conditions

• Status: Recruiting
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 44 (estimated)
• Sponsor: Addpharma Inc. · Industry
• Sex: Male
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 Under Fed Conditions in Healthy Adult Male Subjects

Conditions

• Benign Prostatic Hyperplasia

Interventions

Type	Name	Description
DRUG	AD-116, AD-1161	Single-dose oral administration of AD-116 or AD-1161, according to randomized sequence.

Timeline

• Start date: 2026-02-26
• Primary completion: 2026-04-22
• Completion: 2026-05-08
• First posted: 2026-03-02
• Last updated: 2026-03-03

Locations

1 site across 1 country: South Korea